Pinealon

10mg Vial

20mg Vial

2 September 2026Updated 2 September 2026

Pinealon

Overview Research0 Mechanism Protocols Safety

Discussions

This is Premium content Premium

Create a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for Pinealon.

Create free account Member login

Full range of benefits for Pinealon

Neuroprotective effects in preclinical models

May improve learning and memory in animal studies

Reduces oxidative stress and lipid peroxidation in tissues

Supports neuronal survival and anti-apoptotic pathways

Modulates age-related cellular markers in preclinical research

May enhance mitochondrial function and energy metabolism

Shows anti-inflammatory effects in some animal studies

May modulate stress-related neuroendocrine responses

Preclinical evidence for improved synaptic plasticity

Small peptide with preclinical evidence of CNS bioavailability

This peptide's combination-safety and interaction data below always stays visible, regardless of membership.

Warning

Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.

Peptide Interactions

// 20 known interactions

Synergistic(5)Compatible(5)Monitor(5)Avoid(5)

Not recommended for concurrent use

Pregnancy and breastfeeding

Use with caution due to lack of robust safety data in pregnant or lactating patients and evaluate risk–benefit on an individual basis.

Cytotoxic chemotherapy (e.g., alkylating agents, antimetabolites)

Exercise caution and consult oncology because peptides with cell‑protective or proliferative effects could theoretically interfere with cytotoxic treatment effects or wound healing.

Immunostimulants/interferons

Caution advised when combining with agents that strongly modulate immune activation due to uncertain additive or opposing immunologic effects.

Hormone replacement therapy (estrogen/progestin)

Evaluate endocrine status and risks before combining because Pinealon originates from pineal physiology and potential endocrine interactions have not been fully characterised.

Unregulated peptide/legal supplement mixtures

Avoid or review carefully because coadministration with non‑standardised or multi‑ingredient products increases risk of unexpected interactions and adverse effects.

All interaction categories

Synergistic (5)

Epithalon (epitalon): Complementary pineal gland peptide that may have additive geroprotective and neuroprotective effects when combined with Pinealon, based on limited preclinical and early clinical observations.
Melatonin: Acts on circadian regulation and possesses antioxidant properties that can complement Pinealon's reported neuroprotective and chronobiotic effects.
Omega‑3 fatty acids (DHA/EPA): Long‑chain omega‑3s support neuronal membrane health and anti‑inflammatory pathways and may enhance cognitive and neuroprotective outcomes when co‑administered with Pinealon.
Vitamin B12 (cobalamin): Important for neuronal function and repair, B12 supplementation may support and potentially augment Pinealon's neuroprotective effects in patients with deficiency or risk of neuropathy.
Cerebrolysin: A peptide‑based neuroprotective/neurotrophic preparation that could have complementary mechanisms to Pinealon in neurorehabilitation settings, although evidence is limited and additive effects are theoretical.

Compatible (5)

Statins (e.g., atorvastatin): No known direct pharmacologic interaction with Pinealon and commonly co‑administered in populations receiving neuroprotective therapies.
ACE inhibitors/ARBs (e.g., lisinopril, losartan): Antihypertensive agents are generally neutral with respect to Pinealon pharmacology and require no special adjustment solely for coadministration.
Metformin: Widely used antidiabetic with no established interaction with Pinealon, permitting routine coadministration while managing glycemic control per standard practice.
Multivitamin/mineral supplements: General micronutrient supplementation is compatible with Pinealon and does not typically necessitate special monitoring beyond routine clinical care.
Low‑dose aspirin (antiplatelet): Commonly used for cardiovascular prophylaxis and considered neutral in coadministration with Pinealon absent other bleeding risk factors.

Monitor (5)

Anticoagulants (warfarin, DOACs): Although direct interactions are not established, monitor for bleeding and INR or appropriate anticoagulant levels because peptide therapies can unpredictably affect physiology in vulnerable patients.
Antidiabetic agents (insulin, sulfonylureas): Monitor blood glucose and adjust antiglycaemic dosing as clinically indicated because neuroactive peptides can occasionally influence metabolic parameters.
Immunosuppressants (cyclosporine, tacrolimus): When combining with agents that alter immune function, monitor clinical response and drug levels because Pinealon's immunomodulatory potential is incompletely characterised.
Antiepileptic drugs (e.g., phenytoin, valproate): Monitor seizure control and therapeutic drug levels if applicable, as neuroactive peptide coadministration can theoretically alter neuronal excitability or drug tolerance.
Psychotropic medications (SSRIs/SNRIs): Monitor mood, cognition, and adverse effects because additive central nervous system effects are possible and clinical data on combined use are limited.

Avoid (5)

Pregnancy and breastfeeding: Use with caution due to lack of robust safety data in pregnant or lactating patients and evaluate risk–benefit on an individual basis.
Cytotoxic chemotherapy (e.g., alkylating agents, antimetabolites): Exercise caution and consult oncology because peptides with cell‑protective or proliferative effects could theoretically interfere with cytotoxic treatment effects or wound healing.
Immunostimulants/interferons: Caution advised when combining with agents that strongly modulate immune activation due to uncertain additive or opposing immunologic effects.
Hormone replacement therapy (estrogen/progestin): Evaluate endocrine status and risks before combining because Pinealon originates from pineal physiology and potential endocrine interactions have not been fully characterised.
Unregulated peptide/legal supplement mixtures: Avoid or review carefully because coadministration with non‑standardised or multi‑ingredient products increases risk of unexpected interactions and adverse effects.